FDA Panel Recommends Boosters For High Risk Or 65+ But Not For Younger

Image of a vaccine shot

An advisory committee to the FDA has recommended authorizing booster shots of the Pfizer-BioNTech coronavirus vaccine for those 65  or older or those at risk of severe cases of COVID-19. But the committee declined to approve boosters for the general population citing lack of compelling evidence. Continue reading “FDA Panel Recommends Boosters For High Risk Or 65+ But Not For Younger”